Travere Therapeutics Files Form 4
Ticker: TVTX · Form: 4 · Filed: Apr 16, 2026
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Travere Therapeutics filed a Form 4 on 4/15/26 showing ownership changes.
AI Summary
On April 15, 2026, Travere Therapeutics, Inc. filed a Form 4, indicating changes in beneficial ownership of securities. The report covers the period ending April 13, 2026. Elizabeth E. Reed is listed as the reporting person.
Why It Matters
Form 4 filings disclose insider transactions, providing insights into the buying or selling activities of company executives and major shareholders.
Risk Assessment
Risk Level: low — A Form 4 filing itself is a routine disclosure and does not inherently represent a high-risk event.
Key Players & Entities
- Travere Therapeutics, Inc. (company) — Issuer
- Elizabeth E. Reed (person) — Reporting Person
- 0001438533 (company) — Issuer CIK
- 0001283303 (company) — Reporting Person CIK
FAQ
What type of filing is this?
This is a Form 4 filing, a Statement of changes in beneficial ownership of securities.
When was the filing accepted by the SEC?
The filing was accepted on April 15, 2026, at 21:47:34.
What is the period of report for this filing?
The period of report is April 13, 2026.
Who is the reporting person listed in the filing?
Elizabeth E. Reed is listed as the reporting person.
What is the CIK for Travere Therapeutics, Inc.?
The CIK for Travere Therapeutics, Inc. is 0001438533.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 16, 2026 by Elizabeth E. Reed regarding Travere Therapeutics, Inc. (TVTX). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.